发明名称 |
PYRAZOLO[3,4-G]QUINOXALINE COMPOUNDS WHICH INHIBIT PDGF RECEPTOR PROTEIN TYROSINE KINASE |
摘要 |
This invention relates to pyrazolo¢3,4-g!quinoxaline compounds exhibiting protein tyrosine kinase inhibition activity. More specifically, compounds of this invention are novel as selective inhibitors of the PDGF-R protein tyrosine kinase and can be applied as potential therapeutic agents for various disease states which are characterized by uncontrolled cellular proliferation. Further, the present invention provides pharmaceutical compositions and a method for treating such disorders comprising the administration to a patient of a PDGF receptor inhibiting effective amount of a pyrazolo¢3,4-g!quinoxaline compound exhibiting protein tyrosine kinase inhibition activity. Processes for the preparation of pyrazolo¢3,4-g!quinoxaline compounds.
|
申请公布号 |
CA2198005(A1) |
申请公布日期 |
1996.03.14 |
申请号 |
CA19952198005 |
申请日期 |
1995.09.06 |
申请人 |
RHONE-POULENC RORER PHARMACEUTICALS INC. |
发明人 |
MYERS, MICHAEL R.;PERSONS, PAUL E.;LY, CUONG Q.;SPADA, ALFRED P. |
分类号 |
A61K31/495;A61P9/10;A61P13/02;A61P15/00;A61P29/00;A61P35/00;A61P35/02;C07D487/04;(IPC1-7):C07D487/04 |
主分类号 |
A61K31/495 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|